Researcher Bios

Learn more about the backgrounds, scientific pursuits and personal interests of the members of our research team. These individuals are committed to pursuing Bristol-Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.
Beatrice Anduze-Faris, M.D.

Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations

Bryan (Bo) Barnhart, Ph.D.

Senior Director, Immuno-Oncology, Discovery

Michaela Bowden

Director, Translational Biology

Cynthia Brogdon, RN, Ph.D.

Head, Oncology Portfolio Strategy, Oncology Medical

Edgar Charles, M.D.

Clinical Development Lead, pegylated FGF21

Sharon Cload, Ph. D.

Vice President, Molecular Discovery Technologies

Binodh DeSilva, Ph.D.

Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

Melissa Harris, B.Sc, PharmD

Development Team lead for Fibrosis, Cardiovascular, Fibrosis & Immunoscience

Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology 

Charlotte Jones-Burton, M.D., M.S.

Cardiovascular Development Team Lead, Innovative Medicines 

Emma Lees, Ph.D.

Vice President, & Site Head of R&D, Oncology Discovery, Cambridge, MA

Michael May, Ph.D.

Countrywide Medical Director, Germany, Global Medical

Michael C. Montalto, Ph.D.

Vice President, Pathology & Clinical Biomarker Laboratories

Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery

Mike Quigley, Ph.D.

Vice President, Head of Oncology Discovery Biology and Site Head, Redwood City

Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

Saurabh Saha, M.D., Ph.D.

SVP, Global Head of Translational Medicine, Cambridge Site Head

John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D